Jacques Marbehant – Senior Vice President, Head of Global Manufacturing,…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Address: Rue Archimede 11, 1000 Brussels, Belgium
Tel: +32 2 285 4200
Web: http://www.apb.be/Content/Default.asp
The Belgian Pharmaceutical Association (APB) is the federation of the Belgian professional associations of independent pharmacists. The PDB consists of 90% of pharmaceutical bodies, which represents almost all independent pharmacists.
The activities consist of the PDB consist of, on the one hand, to defend the interests of its members and, while on the other hand, to provide assistance and information necessary for the exercise of their profession.
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…